ArticleBMC infectious diseases2026
Association between trajectory of estimated plasma volume status and ICU mortality in sepsis patients: a retrospective cohort study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThis study aims to elucidate the association between estimated plasma volume status (ePVS) trajectory changes and intensive care unit (ICU) mortality.
methodsData were extracted from the MIMIC-IV (version 3.1) database from 2008 to 2022. Patients aged 18 to 80 years who met the Sepsis-3 criteria were included. Patients who were not in their first hospital admission or first ICU stay, had an ICU stay shorter than 7 days or longer than 100 days, or lacked sufficient hemoglobin or hematocrit data to calculate ePVS at the required time points were excluded. Group-based trajectory modeling (GBTM) was used to identify distinct ePVS trajectories. Kaplan-Meier survival curves and Cox proportional hazards models were used to compare ICU mortality across ePVS trajectory groups. Restricted cubic splines (RCS) were used to analyze the dose-response relationship between Day 1 ePVS and outcomes.
resultsAmong 5208 patients with sepsis, three distinct ePVS trajectories were identified, namely Trajectory 1 (low-ascend), Trajectory 2 (medium-ascend), Trajectory 3 (high-ascend). Kaplan–Meier analysis showed Trajectory 1 having the highest survival probability among the ePVS trajectories. After multivariable adjustment, Trajectory 3 remained significantly associated with a higher risk of ICU mortality compared with Trajectory 1, with a hazard ratio (HR) of 1.20 (95%CI 1.01–1.44, p = 0.039). RCS analysis showed a significant linear association between Day 1 ePVS and ICU mortality. Subgroup analyses showed generally consistent results, and no significant interactions were detected.
conclusionDistinct ePVS trajectories were associated with ICU mortality in sepsis patients, with the high-ascend trajectory showing the highest mortality risk. CLINICAL TRIAL: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.